Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Income Statement
Earnings Waterfall
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Revenue
|
34.4B
CNY
|
Cost of Revenue
|
-12.2B
CNY
|
Gross Profit
|
22.2B
CNY
|
Operating Expenses
|
-9.8B
CNY
|
Operating Income
|
12.3B
CNY
|
Other Expenses
|
-999.6m
CNY
|
Net Income
|
11.3B
CNY
|
Income Statement
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||
Revenue |
12 507
N/A
|
13 109
+5%
|
13 753
+5%
|
14 423
+5%
|
15 150
+5%
|
15 853
+5%
|
16 556
+4%
|
17 391
+5%
|
18 915
+9%
|
20 240
+7%
|
21 026
+4%
|
22 066
+5%
|
23 240
+5%
|
24 354
+5%
|
25 270
+4%
|
26 432
+5%
|
27 847
+5%
|
29 174
+5%
|
30 366
+4%
|
31 787
+5%
|
33 486
+5%
|
34 374
+3%
|
|
Gross Profit | |||||||||||||||||||||||
Cost of Revenue |
(4 233)
|
(4 512)
|
(4 626)
|
(5 112)
|
(5 444)
|
(5 703)
|
(5 799)
|
(6 304)
|
(6 696)
|
(6 989)
|
(7 459)
|
(7 935)
|
(8 431)
|
(8 985)
|
(8 967)
|
(9 545)
|
(10 254)
|
(10 810)
|
(10 956)
|
(11 626)
|
(12 109)
|
(12 203)
|
|
Gross Profit |
8 275
N/A
|
8 597
+4%
|
9 127
+6%
|
9 311
+2%
|
9 707
+4%
|
10 151
+5%
|
10 757
+6%
|
11 087
+3%
|
12 219
+10%
|
13 251
+8%
|
13 566
+2%
|
14 131
+4%
|
14 809
+5%
|
15 369
+4%
|
16 303
+6%
|
16 887
+4%
|
17 593
+4%
|
18 364
+4%
|
19 410
+6%
|
20 160
+4%
|
21 377
+6%
|
22 171
+4%
|
|
Operating Income | |||||||||||||||||||||||
Operating Expenses |
(4 469)
|
(4 788)
|
(5 081)
|
(5 026)
|
(5 161)
|
(5 311)
|
(5 752)
|
(5 979)
|
(6 078)
|
(6 211)
|
(6 221)
|
(6 216)
|
(6 282)
|
(6 380)
|
(7 422)
|
(7 467)
|
(7 708)
|
(8 156)
|
(8 919)
|
(9 099)
|
(9 895)
|
(9 832)
|
|
Selling, General & Administrative |
(3 618)
|
(3 812)
|
(3 981)
|
(4 016)
|
(4 174)
|
(4 247)
|
(4 425)
|
(4 650)
|
(4 672)
|
(4 740)
|
(4 594)
|
(4 577)
|
(4 604)
|
(4 688)
|
(5 089)
|
(5 265)
|
(5 387)
|
(5 655)
|
(6 152)
|
(6 600)
|
(7 068)
|
(7 052)
|
|
Research & Development |
(1 092)
|
(1 221)
|
(1 203)
|
(1 331)
|
(1 333)
|
(1 383)
|
(1 371)
|
(1 603)
|
(1 664)
|
(1 732)
|
(1 726)
|
(1 976)
|
(2 027)
|
(2 148)
|
(2 295)
|
(2 640)
|
(2 813)
|
(2 982)
|
(2 616)
|
(3 071)
|
(3 424)
|
(3 344)
|
|
Depreciation & Amortization |
0
|
0
|
(213)
|
0
|
0
|
0
|
(261)
|
0
|
0
|
0
|
(305)
|
0
|
0
|
0
|
(520)
|
0
|
0
|
0
|
(661)
|
0
|
0
|
0
|
|
Other Operating Expenses |
241
|
244
|
316
|
321
|
346
|
318
|
306
|
274
|
257
|
260
|
405
|
337
|
349
|
457
|
483
|
438
|
492
|
481
|
511
|
572
|
597
|
564
|
|
Operating Income |
3 805
N/A
|
3 809
+0%
|
4 046
+6%
|
4 286
+6%
|
4 546
+6%
|
4 839
+6%
|
5 005
+3%
|
5 108
+2%
|
6 141
+20%
|
7 040
+15%
|
7 346
+4%
|
7 915
+8%
|
8 527
+8%
|
8 988
+5%
|
8 881
-1%
|
9 420
+6%
|
9 884
+5%
|
10 209
+3%
|
10 491
+3%
|
11 061
+5%
|
11 482
+4%
|
12 339
+7%
|
|
Pre-Tax Income | |||||||||||||||||||||||
Interest Income Expense |
(152)
|
138
|
237
|
204
|
284
|
326
|
488
|
579
|
416
|
138
|
128
|
(25)
|
(58)
|
55
|
182
|
145
|
261
|
474
|
493
|
415
|
828
|
629
|
|
Non-Reccuring Items |
4
|
(3)
|
(5)
|
(2)
|
(2)
|
(3)
|
(114)
|
(2)
|
(2)
|
(2)
|
(24)
|
(2)
|
0
|
2
|
(2)
|
(3)
|
3
|
7
|
3
|
12
|
5
|
4
|
|
Total Other Income |
36
|
29
|
(40)
|
(39)
|
(29)
|
(33)
|
(11)
|
0
|
7
|
(7)
|
(12)
|
(29)
|
(42)
|
(41)
|
(43)
|
(42)
|
(40)
|
(28)
|
(34)
|
(53)
|
(60)
|
(60)
|
|
Pre-Tax Income |
3 692
N/A
|
3 973
+8%
|
4 238
+7%
|
4 448
+5%
|
4 798
+8%
|
5 130
+7%
|
5 368
+5%
|
5 686
+6%
|
6 562
+15%
|
7 169
+9%
|
7 438
+4%
|
7 860
+6%
|
8 428
+7%
|
9 005
+7%
|
9 017
+0%
|
9 520
+6%
|
10 109
+6%
|
10 662
+5%
|
10 954
+3%
|
11 435
+4%
|
12 255
+7%
|
12 912
+5%
|
|
Net Income | |||||||||||||||||||||||
Tax Provision |
(429)
|
(475)
|
(513)
|
(525)
|
(578)
|
(633)
|
(683)
|
(693)
|
(793)
|
(793)
|
(779)
|
(799)
|
(876)
|
(1 044)
|
(1 013)
|
(1 125)
|
(1 160)
|
(1 217)
|
(1 343)
|
(1 359)
|
(1 491)
|
(1 572)
|
|
Income from Continuing Operations |
3 263
|
3 498
|
3 726
|
3 923
|
4 220
|
4 497
|
4 685
|
4 993
|
5 769
|
6 376
|
6 660
|
7 061
|
7 551
|
7 961
|
8 004
|
8 395
|
8 949
|
9 445
|
9 611
|
10 076
|
10 764
|
11 340
|
|
Income to Minority Interest |
(8)
|
(6)
|
(7)
|
(5)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(4)
|
(4)
|
(3)
|
(4)
|
(3)
|
(2)
|
(1)
|
|
Net Income (Common) |
3 255
N/A
|
3 492
+7%
|
3 719
+7%
|
3 918
+5%
|
4 217
+8%
|
4 494
+7%
|
4 681
+4%
|
4 988
+7%
|
5 765
+16%
|
6 373
+11%
|
6 658
+4%
|
7 059
+6%
|
7 548
+7%
|
7 957
+5%
|
8 002
+1%
|
8 392
+5%
|
8 945
+7%
|
9 441
+6%
|
9 607
+2%
|
10 073
+5%
|
10 762
+7%
|
11 339
+5%
|
|
EPS (Diluted) |
2.97
N/A
|
3.19
+7%
|
3.34
+5%
|
3.22
-4%
|
3.47
+8%
|
3.69
+6%
|
3.85
+4%
|
4.1
+6%
|
4.74
+16%
|
5.24
+11%
|
5.48
+5%
|
5.8
+6%
|
6.2
+7%
|
6.54
+5%
|
6.59
+1%
|
6.91
+5%
|
7.38
+7%
|
7.8
+6%
|
7.94
+2%
|
8.33
+5%
|
8.9
+7%
|
9.38
+5%
|